GaldermaReceivesU.S.FDAApprovalforDifferin庐Epiduo庐AcneGelPrescription-to-OTCSwitch
===2026/5/26 0:28:20===
regimen – a level of ease that is critical to building consistent routines and achieving clearer skin over time.
“This approval marks an important milestone in acne care and reflects Galderma’s longstanding leadership in acne and retinoid science. Differin Epiduo pairs two complementary, evidence鈥慴ased actives: adapalene, a highly stable and well鈥憈olerated retinoid developed by Galderma, and benzoyl peroxide, a proven antimicrobial agent. This retinoid-benzoyl peroxide combination aligns with dermatology guidelines, which strongly recommend using both together as a first鈥憀ine, multimodal approach to acne treatment. Bringing this scientifically grounded combination to the OTC setting allows us to extend that legacy to patients across the U.S. while preserving the clinical rigor that underpins its effectiveness.”
=*=*=*=*=*=
当前为第4/10页
下一页-上一页-
=*=*=*=*=*=
返回新闻列表
返回网站首页